Physician profile
Eric Stephen Dilbone
NPI 1043717788
$27,891.08
in general payments reported to CMS, 2019-2025
10 companies · $1,432 in 2025
The $1,432 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13K · 2024: $13K · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,992 · Grant: $8,750 · Food and Beverage: $5,130 · Travel and Lodging: $5,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,992.21 |
| Grant | $8,750.00 |
| Food and Beverage | $5,130.08 |
| Travel and Lodging | $5,018.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $23,701.29 | 2023-2025 | Journey II, Real Intelligence, Or3o Dual Mobility |
| Zimmer Biomet Holdings, INC. | $2,249.53 | 2023-2025 | Persona, Rosa, Oxford |
| Stryker Corporation | $1,456.27 | 2024-2025 | Mako, Insignia, Triathlon |
| Intellijoint Surgical INC. | $153.72 | 2025 | Intellijoint Hip |
| Medacta USA, INC. | $118.04 | 2023 | Gmk Sphere |
| Peerless Surgical INC. | $87.26 | 2024-2025 | |
| Onkos Surgical, INC. | $39.37 | 2024 | Eleos Limb Salvage System |
| Heron Therapeutics, INC. | $36.58 | 2024 | Zynrelef |
| Davol INC. | $29.33 | 2025 | Arista |
| Bioventus LLC | $19.69 | 2024 | Gelsyn-3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Dilbone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.